Integration of chemotherapy into combined modality treatment of solid tumors. 1. The overall strategy.

[1]  N. Wolmark,et al.  New concepts in the management of primary breast cancer , 1975, Cancer.

[2]  R. Symmonds,et al.  Some surgical aspects of gynecologic cancer , 1975, Cancer.

[3]  G. Bonadonna,et al.  Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5‐fluorouracil for advanced breast cancer , 1975, Cancer.

[4]  C. Redmond,et al.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. , 1975, The New England journal of medicine.

[5]  E. J. Macdonald.  THE EPIDEMIOLOGY OF MELANOMA , 1963, Progress in clinical cancer.

[6]  M. Slavik,et al.  Methyl-CCNU inclinical cancer therapy. , 1974, Cancer treatment reviews.

[7]  M. Piver,et al.  Hydroxyurea and radiation therapy in advanced cervical cancer. , 1974, American Journal of Obstetrics and Gynecology.

[8]  L. Lagasse,et al.  Combination Adriamycin and radiation therapy in gynecologic cancers. , 1974, Gynecologic oncology.

[9]  L. Einhorn,et al.  Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin. , 1974, The New England journal of medicine.

[10]  D. Tormey,et al.  Combination chemotherapy of carcinoma of the breast , 1974 .

[11]  C. Lappas,et al.  Experimental chemotherapy in carcinoma of the cervix. , 1974, International surgery.

[12]  D. Cramer,et al.  Trends in the incidence of endometrial cancer in the United States. , 1974, Gynecologic oncology.

[13]  G. Ramírez,et al.  Five‐drug therapy in advanced breast cancer. Factors Influencing Toxicity and Response , 1974, Cancer.

[14]  L. Einhorn,et al.  Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. , 1974, Cancer research.

[15]  J. Blom,et al.  Combination chemotherapy in disseminated carcinoma of the breast. , 1974, Oncology.

[16]  M. Slavik,et al.  Review of CCNU in clinical cancer therapy , 1974 .

[17]  S. Carter.  The chemical therapy of breast cancer. , 1974, Seminars in oncology.

[18]  S. Carter,et al.  Integration of chemotherapy into combined modality treatment of solid tumors: 1. The overall strategy , 1974 .

[19]  D. Ahmann,et al.  Evaluation of l‐(2‐chloroethyl‐3‐4‐methylcyclohexyl)‐l‐nitrosourea (methyl‐CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45388) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma , 1974, Cancer.

[20]  S K Carter,et al.  Adriamycin. A new anticancer drug with significant clinical activity. , 1974, Annals of internal medicine.

[21]  H. Bruckner,et al.  Effect of imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno) on immunity in patients with malignant melanoma. , 1974, Cancer research.

[22]  W. Creasman,et al.  Methotrexate, hydroxyurea, and vincristine: Combination chemotherapy in squamous carcinoma of the female genitalia , 1973 .

[23]  F. Martin,et al.  Cyclophosphamide-induced ovarian failure. , 1973, The New England journal of medicine.

[24]  R. Hahn,et al.  A phase 2 study of intermittent high-dose cyclophosphamide therapy of advanced gastrointestinal cancer. , 1973, Cancer research.

[25]  M. Piver,et al.  Adriamycin and bleomycin, alone and in combination, in gynecologic cancers , 1973, Cancer.

[26]  R. Gerner,et al.  Chemotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and dactinomycin , 1973, Cancer.

[27]  G. Wilbanks,et al.  Combination chemotherapy with bleomycin and methotrexate in recurrent and disseminated cervical carcinoma: A preliminary study , 1973 .

[28]  B. Hoogstraten,et al.  CCNU (1‐[2‐chloroethyl]‐3‐cyclohexyl‐1‐nitrosourea, NSC‐79037) in the treatment of cancer. Phase II study , 1973, Cancer.

[29]  G. Rosen,et al.  Adriamycin—an antitumor antibiotic in the treatment of neoplastic diseases , 1973, Cancer.

[30]  G. Bonadonna,et al.  Phase II evaluation of adriamycin in human neoplasia , 1973, Cancer.

[31]  E. Hersh,et al.  Active immunotherapy with B.C.G. for recurrent malignant melanoma. , 1973, Lancet.

[32]  Omura Ga.  Chemotherapy and hormone therapy in gynecologic cancer. , 1973 .

[33]  D Grob,et al.  Vincristine treatment of advanced cancer: a cooperative study of 392 cases. , 1973, Cancer research.

[34]  V. Devita,et al.  The use of drugs in combination for the treatment of cancer: rationale and results. , 1973, The New England journal of medicine.

[35]  B. Fisher.  Cooperative clinical trials in primary breast cancer: A critical appraisal , 1973, Cancer.

[36]  G. Bonadonna,et al.  Combination Chemiotherapy with 5-(3,3 dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) and Vincristine (VCR; NSC - 67574) in Metastatic Malignant Melanoma , 1973, Tumori.

[37]  J. Cohen,et al.  GLC assay for 5-fluorouracil in biological fluids. , 1973, Journal of pharmaceutical sciences.

[38]  S. Carter,et al.  A clinical review of bleomycin—a new antineoplastic agent , 1973, Cancer.

[39]  R. Livingston,et al.  Hexamethylmelamine--a new drug with activity in solid tumors. , 1973, European journal of cancer.

[40]  H. Hansen,et al.  1-2(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU, NSC-79037): a comparison of drug administration at four-week and six-week intervals. , 1973, European journal of cancer.

[41]  P. Wrigley,et al.  Management of Adult Acute Myelogenous Leukaemia , 1973, British medical journal.

[42]  G. Bonadonna,et al.  Treatment of Metastatic Breast Cancer with Cyclophosphamide, Methotrexate, Vincristine and Fluorouracil. , 1973 .

[43]  E. Hersh,et al.  Immunotherapy of cancer in man : scientific basis and current status , 1973 .

[44]  N. Bleehen,et al.  Early Clinical Experience with Bleomycin in the United Kingdom in Series of 105 Patients , 1972, British medical journal.

[45]  B. Fisher.  Surgical adjuvant therapy for breast cancer , 1972, Cancer.

[46]  S. Carter.  Single and combination nonhormonal chemotherapy in breast cancer , 1972, Cancer.

[47]  J. Luce.  Chemotherapy of malignant melanoma , 1972, Cancer.

[48]  R. Lenhard,et al.  Therapy of malignant melanoma with an imidazole carboxamide and bis‐chloroethyl nitrosourea , 1972, Cancer.

[49]  S. George,et al.  Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanoma. , 1972, Cancer research.

[50]  D. Ahmann,et al.  A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and imidazole carboxamide (NSC 45388) with vincristine (NSC 67574) in the palliation of disseminated malignant melanoma. , 1972, Cancer research.

[51]  H. Averette,et al.  Exploratory celiotomy for surgical staging of cervical cancer. , 1972, American journal of obstetrics and gynecology.

[52]  G. Higgins,et al.  The role of preoperatiave irradiation in cancer of the rectum and rectosigmoid. , 1972, The Surgical clinics of North America.

[53]  A. Garin,et al.  Results of treatment of malignant tumors with ftorafur , 1972, Cancer.

[54]  J. Stambaugh,et al.  The absorption and metabolism of dibromodulcitol in patients with advanced cancer , 1972, Clinical pharmacology and therapeutics.

[55]  T. Godfrey,et al.  Clinical experience with mitomycin C in large infrequent doses , 1972, Cancer.

[56]  S. Cohen,et al.  Triple combination chemotherapy of disseminated melanoma , 1972, Cancer.

[57]  J. Hayward,et al.  Treatment of Early Breast Cancer: A Report after Ten Years of a Clinical Trial , 1972, British medical journal.

[58]  J. Holland,et al.  Comparison of treatment of metastatic gastrointestinal cancer with 5‐fluorouracil (5‐FU) to a combination of 5‐FU with cytosine arabinoside , 1972, Cancer.

[59]  G. Crile.  The case for local excision of breast cancer in selected cases. , 1972, Lancet.

[60]  A. Bluming,et al.  Immunological effects of BCG in malignant melanoma: two modes of administration compared. , 1972, Annals of internal medicine.

[61]  P. Neiman,et al.  High‐dose cyclophosphamide therapy for malignant disease. Toxicity, tumor response, and the effects of stored autologous marrow , 1972 .

[62]  S. Carter,et al.  5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma. , 1972, European journal of cancer.

[63]  F. Schabel,et al.  1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review. , 1972, Advances in cancer research.

[64]  N. A. Steklenev,et al.  Treatment with 5-fluorouracil in prophylaxis of relapses and metastases of stomach cancer. , 1972, Neoplasma.

[65]  G. Ramírez,et al.  Combination phase 1-II study of imidazole carboxamide (NCS45388). , 1972, Oncology.

[66]  H. Leveen,et al.  Preoperative radiation and surgery for cancer of the sigmoid colon and rectum. , 1972, American Journal of Surgery.

[67]  C. Vaughn,et al.  Combined 5-fluorouracil and vinblastine therapy for gastrointestinal and other solid tumors. , 1972, Oncology.

[68]  S. Carter,et al.  International Symposium on Adriamycin , 1972, Springer Berlin Heidelberg.

[69]  J. Bruce.  Operable cancer of the breast. A controlled clinical trial , 1971, Cancer.

[70]  J. Urban,et al.  Selecting variations in extent of surgical procedure for breast cancer , 1971, Cancer.

[71]  J. Wolter,et al.  Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma , 1971, Clinical pharmacology and therapeutics.

[72]  G. Westbury,et al.  Seventy-Five Cases of Solid Tumours Treated by a Modified Quadruple Chemotherapy Regime , 1971, British Journal of Cancer.

[73]  Forrest Ap.  Fifteenth Lister Memorial lecture: rationalization of the management of breast cancer. , 1971 .

[74]  G. Hill,et al.  Improved systemic chemotherapy for malignant melanoma. , 1971, American journal of surgery.

[75]  W. Reeves,et al.  Treatment of cancer with weekly intravenous 5‐fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG) , 1971, Cancer.

[76]  E. Jacobs,et al.  Chemotherapy of metastatic malignant melanoma. Experience with 73 patients , 1971, Cancer.

[77]  A. Parry.  Homer as Artist , 1971, The Classical Quarterly.

[78]  G. Higgins,et al.  Fluorouracil as an adjuvant to surgery in carcinoma of the colon. , 1971, Archives of surgery.

[79]  R. E. Chanes,et al.  Combined actinomycin D and vincristine in the treatment of patients with cancer , 1971, Cancer.

[80]  M. Black,et al.  Prognostic significance of microscopic structure of gastric carcinomas and their regional lymph nodes , 1971, Cancer.

[81]  W. McCarthy,et al.  Imidazole carboxamide therapy in advanced malignant melanoma , 1971, Cancer.

[82]  E. Gehan,et al.  Further clinical studies of combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5-flourouracil in solid tumors , 1971, The American journal of the medical sciences.

[83]  S. Wallace,et al.  The accuracy of lymphangiography in carcinoma of the uterine cervix. , 1971, The American journal of roentgenology, radium therapy, and nuclear medicine.

[84]  W. Dixon,et al.  Use of Triethylenethiophosphoramide as an Adjuvant to the Surgical Treatment of Gastric and Colorectal Carcinoma: Ten‐Year Follow‐up , 1971, Annals of surgery.

[85]  J. Haybittle,et al.  Treatment of stage-II carcinoma of the female breast. , 1966, Lancet.

[86]  J. Gottlieb,et al.  Clinical evaluation of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide in malignant melanoma and other neoplasms: comparison of twice-weekly and daily administration schedules. , 1971, Oncology.

[87]  L. Irwin,et al.  5‐fluorouracil given once weekly: Comparison of intravenous and oral administration , 1971, Cancer.

[88]  R. Finney.  Adjuvant chemotherapy in the radical treatment of carcinoma of the breast--a clinical trial. , 1971, The American journal of roentgenology, radium therapy, and nuclear medicine.

[89]  J. Bauer,et al.  Cytembena treatment of advances and relapsing uterine cervix carcinoma. , 1971, Neoplasma.

[90]  A. Mittelman,et al.  Renal toxicity in man treated with mitomycin C , 1971, Cancer.

[91]  E. Frei,et al.  Clinical trials with adriamycin , 1971, Cancer.

[92]  J. Horton,et al.  5-Fluorouracil in Cancer: An Improved Regimen , 1970 .

[93]  B. Morson,et al.  Pathology and prognosis of carcinoma of the stomach , 1970, The British journal of surgery.

[94]  B. Kennedy,et al.  T N M classification for stomach cancer , 1970, Cancer.

[95]  William H. J. Haffner,et al.  Intermittent intravenous methotrexate in the treatment of advanced epidermoid carcinoma of the cervix and vulvovagina , 1970, Cancer.

[96]  B. Fisher,et al.  Postoperative Radiotherapy in the Treatment of Breast Cancer: Results of the NSABP Clinical Trial , 1970, Annals of surgery.

[97]  J. H. Moon,et al.  Combination chemotherapy in malignant melanoma , 1970, Cancer.

[98]  J. Edmonson,et al.  A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878). , 1970, Cancer research.

[99]  R. Hahn,et al.  Combination chemotherapy in gastrointestinal cancer. , 1970, Cancer research.

[100]  J. C. Burch,et al.  Preoperative radium irradiation and radical hysterectomy in the treatment of cancer of the cervix. , 1970, American journal of obstetrics and gynecology.

[101]  H. Bisel,et al.  Prolonged low‐dosage administration of hexamethylmelamine (NC 13875) , 1970, Cancer.

[102]  P. Saunders,et al.  Studies of the mechanism of action of the antitumor agent 5(4)-(3,3-dimethyl-1-triazeno) imidazole-4(5)-carboxamide in Bacillus subtilis. , 1970, Biochemical pharmacology.

[103]  I. Ariel.  Therapeutic effects of hydroxyurea. Experience with 118 patients with inoperable solid tumors , 1970, Cancer.

[104]  M. Stearns,et al.  Palliative radiation therapy in patients with cancer of the colon and rectum , 1970, Cancer.

[105]  H. Leis.  Diagnosis and treatment of breast lesions , 1970 .

[106]  R. Livingston,et al.  Single Agents in Cancer Chemotherapy , 1970, Springer US.

[107]  B. Kennedy,et al.  Hormone therapy in inoperable breast cancer , 1969 .

[108]  E. Dahl-iversen,et al.  Radical Mastectomy with Parasternal and Supraclavicular Dissection for Mammary Carcinoma , 1969, Annals of surgery.

[109]  I D Bross,et al.  Therapeutic implications from a mathematical model characterizing the course of breast cancer , 1969, Cancer.

[110]  I D Bross,et al.  Cancer of the breast: Size of neoplasm and prognosis , 1969, Cancer.

[111]  C. Moertel,et al.  Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. , 1969, Lancet.

[112]  R. Keehn,et al.  Use of 5‐fluorodeoxyuridine (FUDR) as an adjuvant to the surgical management of carcinoma of the stomach , 1969, Cancer.

[113]  J. Bickers,et al.  Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878). , 1969, Cancer research.

[114]  G. Mathé,et al.  Active immunotherapy for acute lymphoblastic leukaemia. , 1969, Lancet.

[115]  C. Coltman,et al.  Combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5‐fluorouracil in solid tumors , 1969 .

[116]  W. Clark,et al.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin. , 1969, Cancer research.

[117]  T. Hall,et al.  Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature. , 1969, Cancer research.

[118]  H. Bisel,et al.  Phase II study of hexamethylmelamine (NSC 13875) , 1969, Cancer.

[119]  J. Luce,et al.  Treatment of cancer with weekly intravenous 5‐fluorouracil , 1968, Cancer.

[120]  J. Daly,et al.  Combination of 5‐Fluorouracil and Radiation as Primary Therapy of Carcinoma of the Cervix , 1968, Obstetrics and gynecology.

[121]  R K Ausman,et al.  Surgical Adjuvant Chemotherapy in Cancer of the Breast: Results of a Decade of Cooperative Investigation , 1968, Annals of surgery.

[122]  J. Smith,et al.  Treatment of melanoma by lymphatic perfusion and regional lymph node excision: a preliminary report. , 1968, The American surgeon.

[123]  H. Lessner,et al.  BCNU (1,3), BIS(B‐chloroethyl)‐1‐nitrosourea. Effects on advanced Hodgkin's disease and other neoplasia , 1968, Cancer.

[124]  G. Robertson,et al.  Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses. , 1968, Canadian Medical Association journal.

[125]  I. Henderson,et al.  Clinical evaluation of combined radiation and chemotherapy in gastrointestinal malignancies. , 1968, The American journal of roentgenology, radium therapy, and nuclear medicine.

[126]  J. Van Dyk,et al.  The chemotherapy of malignant melanoma. , 1968, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[127]  B. Pasternack,et al.  A five year progress report on the effectiveness of intraluminal chemotherapy (5-fluorouracil) adjuvant to surgery for colorectal cancer. , 1968, American journal of surgery.

[128]  P. Carbone,et al.  A clinical evaluation of dose and schedule of administration of cytosine arabinoside (NSC 63878). , 1968, Cancer research.

[129]  W. Vogler,et al.  Methotrexate for advanced cancer of the breast , 1968, Cancer.

[130]  C. Vaughn,et al.  Phase 1 trial of porfiromycin , 1967 .

[131]  G. Wilbanks,et al.  Radical hysterectomy and pelvic lymphadenectomy with and without preoperative radiotherapy for cervical cancer. A report of 265 patients followed 10 to 22 years. , 1967, American journal of obstetrics and gynecology.

[132]  P. Cassileth,et al.  Treatment of malignant melanoma with hydroxyurea. , 1967, Cancer research.

[133]  A. Goldin,et al.  Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea. , 1967, Cancer research.

[134]  W. Dixon,et al.  The Use Of Triethylenethiophosphoramide As An Adjuvant To The Surgical Treatment Of Colorectal Carcinoma , 1967, Annals of surgery.

[135]  J. Smith,et al.  Systemic chemotherapy for carcinoma of the cervix. , 1967, American journal of obstetrics and gynecology.

[136]  G. Crile.  The smaller the cancer, the bigger the operation? Rationale of small operations for small tumors and large operations for large tumors. , 1967, JAMA.

[137]  Roy Dk.  Treatment of advanced or recurrent carcinoma of the cervix by cytotoxic drugs. , 1967 .

[138]  N. Blokhin,et al.  5‐Fluorouracil therapy for cancer of the stomach , 1967 .

[139]  A. Postel,et al.  Induced remission of malignant melanoma with actinomycin D. Immunologic implications , 1967, Cancer.

[140]  R. Talley,et al.  Clinical pharmacology and human antitumor activity of cytosine arabinoside , 1967, Cancer.

[141]  P. Calabresi,et al.  Biochemical and pharmacological studies with 1-beta-D-arabinofuranosylcytosine in man. , 1966, Biochemical pharmacology.

[142]  M. Griem,et al.  Modification of radiation response of tissue by colchicine. A clinical evaluation. , 1966, The American journal of roentgenology, radium therapy, and nuclear medicine.

[143]  C. Griffiths,et al.  Time and vehicle studies of a safe and effective method for administration of 5‐fluorouracil , 1966, Cancer.

[144]  V. Devita,et al.  Preliminary clinical studies with ibenzmethyzin , 1966, Clinical pharmacology and therapeutics.

[145]  H. Ellis,et al.  A trial of mithramycin in the treatment of advanced malignant disease. , 1966, British Journal of Cancer.

[146]  Y. Shealy,et al.  Complete Inhibition of Mouse Leukaemia L1210 by 5(or 4)-[3,3-Mbis (2-Chloroethyl)-l-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196) , 1966, Nature.

[147]  L. Manheimer,et al.  Mitomycin‐C in the therapy of far‐advanced malignant tumors , 1966, Cancer.

[148]  W. H. Bond,et al.  Treatment of neoplastic diseases with an improved oral preparation of vinblastine sulfate , 1966, Cancer.

[149]  L. Esteves,et al.  Chemotherapy of advanced cancer of the cervix. Experience in 55 cases treated with cyclophosphamide. , 1966, American journal of obstetrics and gynecology.

[150]  J. Nelson,et al.  The role of chemotherapy in the treatment of gynecologic malignancy. , 1965, American journal of obstetrics and gynecology.

[151]  J. Edmonson,et al.  Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962. , 1965, Cancer research.

[152]  H. Wilson,et al.  The Use of Low Dosage Drug Regimens in the Treatments of Neoplastic Disease. , 1965 .

[153]  V. Vaitkevicius,et al.  Comparison of cyclophosphamide and 5‐fluorouracil in the treatment of patients with metastatic breast cancer , 1965, Clinical pharmacology and therapeutics.

[154]  P. Rubin.  Can the results be improved by combining radiation and elective radical hysterectomy and lymphadenectomy? Comment. , 1965, JAMA.

[155]  C. Grossi,et al.  Intraluminal chemotherapy adjuvant (HN2 or 5-FU) to operation for cancer of the colon and rectum. Follow-up report of 83 cases. , 1965, Annals of surgery.

[156]  W. Df.  REMARKS OF THE PRESIDENT. , 1965 .

[157]  K. Brunner,et al.  A METHYLHYDRAZINE DERIVATIVE IN HODGKIN'S DISEASE AND OTHER MALIGNANT NEOPLASMS. THERAPEUTIC AND TOXIC EFFECTS STUDIED IN 51 PATIENTS. , 1965, Annals of internal medicine.

[158]  P. Ms,et al.  PROTECTION AGAINST RUBELLA , 1965 .

[159]  N. Bleehen,et al.  Vinblastine Sulphate in the Treatment of Malignant Disease , 1965, British Journal of Cancer.

[160]  M. Reggiani,et al.  ON PHYSICO-CHEMICAL INTERACTIONS BETWEEN DAUNOMYCIN AND NUCLEIC ACIDS. , 1965, Biochimica et biophysica acta.

[161]  C. Moertel,et al.  TREATMENT OF MALIGNANT NEOPLASMS OF THE GASTROINTESTINAL TRACT WITH A COMBINATION OF 5-FLUOROURACIL AND RADIATION: A RANDOMIZED DOUBLE-BLIND STUDY. , 1965, Radiology.

[162]  D. Decker,et al.  SEQUENTIAL RADIATION AND OPERATION IN CARCINOMA OF THE UTERINE CERVIX. , 1965, American journal of obstetrics and gynecology.

[163]  I. Todd.  Natulan in Management of Late Hodgkin's Disease, Other Lymphoreticular Neoplasms, and Malignant Melanoma , 1965, British medical journal.

[164]  W. Vogler,et al.  TOXICITY AND ANTITUMOR EFFECT OF DIVIDED DOSES OF METHOTREXATE. , 1965, Archives of internal medicine.

[165]  M. R. Abell,et al.  Use of thio‐TEPA as an adjuvant to the surgical management of carcinoma of the stomach , 1965, Cancer.

[166]  J. Vaught,et al.  CARCINOMA OF THE CERVIX. RESULTS OF TREATMENT BY RADIATION ALONE AND BY COMBINED RADIATION AND SURGICAL THERAPY IN 335 PATIENTS. , 1965, American journal of obstetrics and gynecology.

[167]  J. Gordon,et al.  Thiotepa and Cyclophosphamide in the Treatment of Advanced Mammary Cancer , 1965, Scottish medical journal.

[168]  C. Smart,et al.  CHEMOTHERAPY OF MALIGNANCIES OF THE GASTROINTESTINAL TRACT. , 1965, American journal of surgery.

[169]  D. Hutchison,et al.  The physiologic disposition of 5‐fluorouracil and 5‐fluoro‐2′‐deoxyuridine in man , 1964, Clinical pharmacology and therapeutics.

[170]  N. Cotten,et al.  Mixed squamous‐cell and adenocarcinoma of the cervix. Combined, adenosquamous, and mucoepidermoid types , 1964, Cancer.

[171]  M. Lado,et al.  THE CHANGING INCIDENCE OF CERVICAL CARCINOMA. , 1964, American journal of obstetrics and gynecology.

[172]  D. Boyes,et al.  THE INFLUENCE OF A CYTOLOGICAL SCREENING PROGRAM UPON THE INCIDENCE OF INVASIVE SQUAMOUS CELL CARCINOMA OF THE CERVIX IN BRITISH COLUMBIA. , 1964, American journal of obstetrics and gynecology.

[173]  K. Myhre,et al.  TREATMENT OF MALIGNANT TUMOURS WITH 5-FLUOROURACIL IN 80 PATIENTS. , 1964, Acta radiologica: therapy, physics, biology.

[174]  D. E. Szilagyi,et al.  MEANING OF FIVE-YEAR CURE IN CANCER OF THE BREAST. , 1964, Archives of surgery.

[175]  B. Shnider,et al.  FURTHER COMPARATIVE TRIAL OF TRIETHYLENE THIOPHOSPHORAMIDE AND MECHLORETHAMINE IN PATIENTS WITH MELANOMA AND HODGKIN'S DISEASE. , 1964, Journal of chronic diseases.

[176]  R. Handley,et al.  Conservative Radical Mastectomy (Patey's Operation) , 1969, Annals of surgery.

[177]  C. Smart,et al.  EARLY RESULTS OF COMBINED RADIATION AND CHEMOTHERAPY IN TREATMENT OF MALIGNANT TUMORS. , 1963, Radiology.

[178]  Groesbeck Hp,et al.  EVALUATION OF 5-FLUOROURACIL (5-FU) IN SURGICAL PRACTICE. , 1963 .

[179]  P. Clifford,et al.  Oral Melphalan Therapy in Advanced Malignant Disease , 1963, British Journal of Cancer.

[180]  J. J. Will,et al.  Vinblastine in Neoplastic Disease Midwest Cooperative Chemotherapy Group , 1963 .

[181]  J. Steinfeld,et al.  Cyclophosphamide. A clinical study. , 1963, JAMA.

[182]  M. Wills,et al.  Bacterial Pyrogen in Diagnosis of Pyelonephritis , 1963, British medical journal.

[183]  C. Heidelberger,et al.  Studies on Fluorinated Pyrimidines XVI. Metabolism of 5-Fluorouracil-2-C14 and 5-Fluoro-2′-deoxyuridine-2-C14 in Cancer Patients , 1963 .

[184]  Daniel S. Martin,et al.  Surgery, Cancer Chemotherapy, Host Defenses, and Tumor Size , 1962 .

[185]  H. Ulfelder,et al.  CHEMOTHERAPY OF CERVICAL CARCINOMA * , 1962, Annals of the New York Academy of Sciences.

[186]  H. Atkins,et al.  Clinical appraisal of cyclophosphamide in malignant neoplasms , 1962, Cancer.

[187]  J. M. Schroeder,et al.  Five years clinical experience with 5-fluorouracil. , 1962, JAMA.

[188]  C. C. Wang,et al.  The role of radiation therapy in the management of carcinoma of the sigmoid, rectosigmoid, and rectum. , 1962, Radiology.

[189]  C. J. Anders,et al.  Cyclophosphamide in Treatment of Disseminated Malignant Disease , 1961, British medical journal.

[190]  L. Carey,et al.  Treatment of advanced cancer of the gastrointestinal tract with antitumor agents. , 1961, Gastroenterology.

[191]  A. Theologides,et al.  The role of 5-fluorouracil in malignant disease. , 1961, Annals of internal medicine.

[192]  D. Karnofsky.  Meaningful clinical classification of therapeutic responses to anticancer drugs , 1961, Clinical pharmacology and therapeutics.

[193]  A. Weiss,et al.  An evaluation of 5-fluorouracil in malignant disease. , 1961, Annals of internal medicine.

[194]  J. Hurley,et al.  A method of selecting patients for cancer chemotherapy. , 1961, Archives of surgery.

[195]  R. Wall,et al.  Cyclophosphamide therapy. Its use in leukemia, lymphoma and solid tumors. , 1961, Archives of internal medicine.

[196]  S. Cade.  Malignant Melanoma: Bradshaw Lecture delivered at the Royal College of Surgeons of England on 7th December 1960 , 1961 .

[197]  R. Ellison.  Clinical applications of the fluorinated pyrimidines. , 1961, The Medical clinics of North America.

[198]  G. Pack,et al.  Metastatic melanoma with indeterminate primary site. Report of two instances of long-term survival. , 1961, JAMA.

[199]  E. Gehan,et al.  The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. , 1961, Journal of chronic diseases.

[200]  E. W. Munnell,et al.  Critical points of failure in the therapy of cancer of the cervix , 1961 .

[201]  V. Vaitkevicius,et al.  Clinical evaluation of cancer chemotherapy with 5‐fluorouracil , 1961, Cancer.

[202]  E. H. Ellison,et al.  Chemotherapy of solid carcinoma. Indications, agents, and results. , 1960, JAMA.

[203]  S. Eisman,et al.  Clinical evaluation of a new alkylating agent: Cytoxan (cyclophosphamide) , 1960, Cancer.

[204]  G. Moore,et al.  CLINICAL STUDIES OF ACTINOMYCIN D , 1960, Annals of the New York Academy of Sciences.

[205]  A. Arneson,et al.  Long-term follow-up observations in cervical cancer. , 1960, American journal of obstetrics and gynecology.

[206]  H. Martin,et al.  Supplementary report on spontaneous return of function following surgical section or excision of the seventh cranial nerve in the surgery of parotid tumors. , 1960, Annals of surgery.

[207]  J. B. Erich,et al.  Malignant melanomas of the head and neck. , 1960, Annals of surgery.

[208]  Emil Frei,et al.  Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide , 1960 .

[209]  N. Trapeznikov.  Results of Surgical Treatment of Cancer of the Stomach , 1959, British medical journal.

[210]  R. Paterson,et al.  Clinical trials in malignant disease: Part III—Breast cancer: Evaluation of post-operative radiotherapy , 1959 .

[211]  D. Slaughter,et al.  Prophylactic and Adjuvant Use of Nitrogen Mustard in the Surgical Treatment of Cancer , 1959, Annals of surgery.

[212]  R. Turell.  DISEASES OF THE COLON AND ANORECTUM , 1959 .

[213]  D. Lyall,et al.  Chemotherapy of Disseminated Carcinoma of the Breast , 1959, Annals of surgery.

[214]  C. Heidelberger,et al.  Studies on fluorinated pyrimidines: VII—the degradative pathway☆☆☆ , 1959 .

[215]  W. Cole,et al.  Adjunctive cancer chemotherapy in surgery of the colon and rectum , 1958, Diseases of the colon and rectum.

[216]  R. S. Boles.  Cancer of the stomach. , 1958, Gastroenterology.

[217]  W. Regelson,et al.  STUDIES OF PHENYLALANINE NITROGEN MUSTARD (CB 3025) IN METASTATIC MALIGNANT MELANOMA OF MAN , 1958, Annals of the New York Academy of Sciences.

[218]  Jane C. Wright,et al.  SUMMARY OF RESULTS OBTAINED WITH CB 1348 , 1958, Annals of the New York Academy of Sciences.

[219]  N. Treves,et al.  An evaluation of therapeutic surgical castration in the treatment of metastatic, recurrent, and primary inoperable mammary carcinoma in women. An analysis of 191 patients , 1958, Cancer.

[220]  R. Fugmann,et al.  A role for chemotherapy as an adjunct to surgery. , 1957, Cancer research.

[221]  W. Cole,et al.  The Prophylactic Treatment of Malignant Disease with Nitrogen Mustard and Triethylenethiophosphoramide (ThioTEPA) , 1957, Annals of surgery.

[222]  W. Daniel,et al.  Treatment of recurrences following initial surgery for cancer of the cervix. , 1957, The Surgical clinics of North America.

[223]  Meyer Hw.  Malignant melanoma; the importance of early aggressive treatment. , 1957 .

[224]  M. Go,et al.  Prophylactic treatment of cancer; the use of chemotherapeutic agents to prevent tumor metastasis. , 1956 .

[225]  F. A. Coller,et al.  THE PROGNOSTIC SIGNIFICANCE OF DIRECT EXTENSION OF CARCINOMA OF THE COLON AND RECTUM , 1954, Annals of surgery.

[226]  G. Nicolosi.  [Tumors of the stomach]. , 1954, Athena; rassegna mensile di biologia, clinica e terapia.

[227]  M. Black,et al.  Lymph node structure in patients with cancer of the breast. , 1953, The American journal of pathology.

[228]  E. Greenspan,et al.  Observations on the effects of the folic acid antagonists, aminopterin and amethopterin, in patients with advanced neoplasms , 1952, Cancer.

[229]  C. P. Rhoads,et al.  The effects of the folic acid antagonists and 2,6‐diaminopurine on neoplastic disease. With special reference to acute leukemia , 1951, Cancer.

[230]  C. Morgan.  Cancer of the rectum. , 1951, Annals of the Royal College of Surgeons of England.

[231]  H. Schlink.  CANCER OF THE CERVIX UTERI , 1950 .

[232]  E. Henriksen.  The lymphatic spread of carcinoma of the cervix and of the body of the uterus; a study of 420 necropsies. , 1949, American journal of obstetrics and gynecology.

[233]  R. Dresser,et al.  Carcinoma of the uterine cervix , 1945 .

[234]  E. H. Pool,et al.  Cancer Cells in the Blood Stream , 1934 .

[235]  C. Dukes,et al.  The classification of cancer of the rectum , 1980 .

[236]  H. D. Caylor,et al.  METAPLASIA IN OVARIAN DERMOIDS AND CYSTADENOMAS REPORT OF THREE CASES , 1922, Annals of surgery.

[237]  W. C. Maccarty.  LONGEVITY IN CANCER: A STUDY OF 293 CASES. , 1922, Annals of surgery.

[238]  G. Ward.  THE BLOOD IN CANCER WITH BONE METASTASES. , 1913 .